Australian startup Mindset Health, has announced it has scored $12m is Series A funding. The company, established in 2018 develops hypnosis-based digital therapeutics apps, addressing health conditions such as, irritable bowel syndrome, menopause, and smoking cessation. The apps are currently available in the UK, U.S, and Australia.
Mindset Health plans to use the funding to expand its offering by developing and launching new digital therapeutics apps in anxiety and depression, sleep, and chronic pain. The company also plans to continue with their clinical and real-world research efforts, to prove the products clinical and economic benefits.
"The global demand for our hypnotherapy programmes – driven by healthcare practitioners who recognise their effectiveness in supporting patients and recommend their use – has proven our thesis and demonstrated the deep market appetite for easy-to-use solutions that can help people manage and live well with underserved health conditions," Mindset Health co-founder Alex Naoumidis said.
Click here to read the original news story.